| Literature DB >> 29581859 |
Chung-Guei Huang1,2,3, Li-Ang Lee4,5, Yi-Cheng Wu5,6, Mei-Jen Hsiao1,3, Jim-Tong Horng1,7, Rei-Lin Kuo1,2, Chih-Heng Huang1,8, Ya-Chu Lin3, Kuo-Chien Tsao1,3, Min-Chi Chen5,9, Tse-Ching Chen5,10, Shin-Ru Shih1,2,3.
Abstract
Avian influenza A(H7N9) virus infections frequently lead to acute respiratory distress syndrome and death in humans. We aimed to investigate whether primary cultures of human respiratory tract epithelial cells are helpful to understand H7N9 virus pathogenesis and tissue tropism, and to evaluate how patient-related characteristics can affect the host's response to infection. Normal human bronchial epithelial cells (isolated from two different donors) and primary epithelial cells (harvested from 27 patients undergoing airway surgery) were experimentally infected with H7N9 and/or H1N1pdm for 72 h. After virus infection, the culture media were collected for viral RNA quantitation and cytokine detection. Both H7N9 and H1N1pdm viruses replicated and induced a cytokine response differently for each donor in the normal human bronchial epithelial model. H7N9 replicated equivalently in epithelial cells harvested from the inferior turbinate and paranasal sinus, and those from the larynx and bronchus, at 72 h post-infection. Viral RNA quantity at 72 h was significantly higher in patients aged 21-64 years than in patients aged ≥ 65 years; however, no effects of sex, medical comorbidities, and obesity were noted. H7N9-infected cultured cells released multiple cytokines within 72 h. Levels of interleukin-1β, interleukin-6, interleukin-8, interferon-γ, and tumor necrosis factor-α were associated differently with patient-related characteristics (such as age, sex, obesity, and medical comorbidities). In the era of precision medicine, these findings illustrate the potential utility of this primary culture approach to predict a host's response to H7N9 infection or to future infection by newly emerging viral infections, and to dissect viral pathogenesis.Entities:
Keywords: avian influenza A(H7N9) virus; cytokine; patient-related characteristics; primary epithelial cells; tropism
Year: 2018 PMID: 29581859 PMCID: PMC5865685 DOI: 10.18632/oncotarget.24537
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Figure 1Changes in viral RNA quantity (panel A) and core cytokine levels (panels B–G) in culture supernatants of normal human bronchial epithelial cell cultures in relation to variables of interest. Normal human bronchial epithelial cells were cultured from a 24-year-old female and a 69-year-old female and experimentally infected with the H7N9 or H1N1pdm virus. Viral RNA quantity (log-transformed) and cytokine values were compared using the Mann–Whitney U test or Kruskal–Wallis test to evaluate their differences at each time point, or a Wilcoxon signed rank test to evaluate their difference between various time points. aP < 0.05.
Viral RNA quantity and cytokine levels in H1N1pdm virus and H7N9 virus-infected culture supernatants harvested from normal human bronchial epithelial cells isolated from two different donors
| 24-year-old female | 69-year-old female | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mock | H1N1pdm | H9N9 | Mock | H1N1pdm | H9N9 | |||||||||
| Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | |||
| Viral RNA quantity (log10 transformation) | ||||||||||||||
| 1 h p.i, | – | – | 3.1 | 0.17 | 2.55 | 0.15 | 0.200 | – | – | 2.77 | 0.11 | 3.02 | 0.09 | 0.100 |
| 24 h p.i. | – | – | 6.51 | 0.12 | 5.95 | 0.08 | 0.100 | – | – | 3.04 | 0.09 | 4.96 | 0.11 | 0.100 |
| 48 h p.i. | – | – | 7.14 | 0.13 | 7.78 | 0.2 | 0.100 | – | – | 3.16 | 0.21 | 5.3 | 0.1 | 0.100 |
| 72 h p.i. | – | – | 7.64 | 0.2 | 8.62 | 0.08 | 0.10 | – | – | 3.02 | 0.16 | 4.58 | 0.43 | 0.700 |
| IL-1β (pg/mL) | ||||||||||||||
| 24 h p.i. | 86.33 | 11.36 | 96.15 | 10.8 | 534.48 | 60.75 | 0.061 | 62.85 | 1.82 | 70.77 | 15.64 | 97.05 | 15.37 | 0.148 |
| 48 h p.i. | 31.95 | 1.28 | 25.33 | 2.62 | 289.02 | 13.13 | 0.039 | 24 | 1.2 | 32.02 | 0.67 | 45.51 | 7.11 | 0.027 |
| 72 h p.i. | 26.24 | 1.02 | 35.52 | 4.21 | 379.3 | 24.76 | 0.039 | 25.46 | 2.2 | 17 | 1.54 | 15.21 | 0.62 | 0.051 |
| IL-6 (pg/mL) | ||||||||||||||
| 24 h p.i. | 81.19 | 14.36 | 91.6 | 2.97 | 17.64 | 3.19 | 0.061 | 112.03 | 17.82 | 76.15 | 11.62 | 68.8 | 11.19 | 0.288 |
| 48 h p.i. | 82.87 | 11.28 | 93.1 | 3.79 | 8.16 | 0.55 | 0.061 | 90.07 | 10.2 | 88.83 | 31.91 | 44.41 | 4.84 | 0.099 |
| 72 h p.i. | 108.42 | 16.02 | 119.69 | 8.8 | 19.46 | 4.1 | 0.051 | 74.7 | 3.2 | 74.36 | 4.72 | 13.15 | 2.09 | 0.066 |
| IL-8 (pg/mL) | ||||||||||||||
| 24 h p.i. | 3146.68 | 116.36 | 3255.66 | 216.57 | 8444.22 | 1814.32 | 0.061 | 1038.79 | 102.33 | 2094.51 | 510.89 | 1473.57 | 144.2 | 0.051 |
| 48 h p.i. | 3549.17 | 280.28 | 2416.11 | 29.04 | 6711.78 | 646.5 | 0.027 | 1464.8 | 181.03 | 2870.38 | 549.54 | 1267.79 | 257.94 | 0.061 |
| 72 h p.i. | 3023.71 | 260.22 | 3156.84 | 203.76 | 22563.5 | 7183.65 | 0.059 | 1387.82 | 152.66 | 1788.49 | 245.31 | 783.81 | 246.22 | 0.079 |
| IFN-γ (pg/mL) | ||||||||||||||
| 24 h p.i. | 0.1 | 0 | 0.1 | 0 | 19.9 | 0.31 | 0.021 | 0.1 | 0 | 0.1 | 0 | 7.45 | 0.7 | 0.022 |
| 48 h p.i. | 0.1 | 0 | 0.1 | 0 | 19.39 | 1.95 | 0.022 | 0.1 | 0 | 0.1 | 0 | 5.22 | 1.02 | 0.021 |
| 72 h p.i. | 0.1 | 0 | 0.1 | 0 | 23.57 | 0.84 | 0.022 | 0.1 | 0 | 0.1 | 0 | 2.92 | 1.33 | 0.022 |
| IP-10 (pg/mL) | ||||||||||||||
| 24 h p.i. | 0.1 | 0 | 6.88 | 3.89 | 4.95 | 0.54 | 0.126 | 0.1 | 0 | 0.1 | 0 | 3.61 | 0.20 | 0.022 |
| 48 h p.i. | 0.1 | 0 | 78.64 | 4.42 | 88.43 | 22.87 | 0.055 | 0.1 | 0 | 0.1 | 0 | 3.84 | 0.53 | 0.022 |
| 72 h p.i. | 6.07 | 0.63 | 668.35 | 1.65 | 377.47 | 76.11 | 0.027 | 0.1 | 0 | 0.1 | 0 | 3.01 | 0.13 | 0.021 |
| TNF-α (pg/mL) | ||||||||||||||
| 24 h p.i. | 9.19 | 1.4 | 6.87 | 0.64 | 9.41 | 1.55 | 0.301 | 6.8 | 0.9 | 9.67 | 3.07 | 4.84 | 0.27 | 0.430 |
| 48 h p.i. | 9.19 | 1.66 | 7.23 | 0.53 | 20.86 | 2.87 | 0.051 | 5.01 | 0.51 | 3.44 | 1.8 | 4.21 | 0.7 | 0.733 |
| 72 h p.i. | 6.26 | 1.52 | 10.33 | 0.98 | 136.81 | 59.94 | 0.039 | 0.1 | 0 | 0.1 | 0 | 1.19 | 0.44 | 0.022 |
Abbreviations: IFN, interferon; IL, interleukin; IP-10, IFN-γ-induced protein-10; p.i., post infection; TNF, tumor necrosis factor.
All values were compared using the Mann–Whitney U test or Kruskal–Wallis test, as appropriate.
Characteristics of patients from whom respiratory tract epithelial cells were obtained
| No. | Site of explant | Age, years | Sex | Medical comorbidities | Obesity |
|---|---|---|---|---|---|
| 1 | Paranasal sinus | 24 | Male | None | No |
| 2 | Inferior turbinate | 48 | Male | HT | Yes |
| 3 | Paranasal sinus | 74 | Male | None | No |
| 4 | Inferior turbinate | 39 | Male | None | Yes |
| 5 | Larynx | 22 | Female | None | Yes |
| 6 | Inferior turbinate | 38 | Male | None | No |
| 7 | Inferior turbinate | 32 | Male | None | No |
| 8 | Inferior turbinate | 38 | Male | DM | Yes |
| 9 | Paranasal sinus | 38 | Male | DM, HT, asthma | Yes |
| 10 | Bronchus | 47 | Female | None | No |
| 11 | Paranasal sinus | 56 | Male | None | No |
| 12 | Inferior turbinate | 49 | Male | None | No |
| 13 | Bronchus | 63 | Female | None | No |
| 14 | Paranasal sinus | 44 | Male | HT | No |
| 15 | Inferior turbinate | 24 | Male | None | No |
| 16 | Bronchus | 62 | Female | None | Yes |
| 17 | Paranasal sinus | 26 | Female | None | No |
| 18 | Bronchus | 43 | Female | None | No |
| 19 | Paranasal sinus | 70 | Male | None | No |
| 20 | Inferior turbinate | 34 | Male | HT | No |
| 21 | Inferior turbinate | 41 | Male | None | No |
| 22 | Bronchus | 61 | Male | None | No |
| 23 | Paranasal sinus | 38 | Male | None | No |
| 24 | Inferior turbinate | 35 | Male | None | Yes |
| 25 | Bronchus | 66 | Female | None | Yes |
| 26 | Paranasal sinus | 78 | Female | HT | No |
| 27 | Inferior turbinate | 40 | Male | HT, asthma | Yes |
Abbreviations: DM, diabetes mellitus; HT, hypertension.
Figure 2Changes in H7N9 viral RNA quantities in primary cultures in relation to variables of interest
All values were log-transformed and compared using generalized estimating equations in which age, sex, medical comorbidity, obesity, and/or anatomical location were included as confounding variables. When all cultures were considered, we observed that viral RNA quantities reached a plateau from 48 to 72 h post-infection (panel A). The anatomical location of the explant was not significantly associated with the viral RNA quantities (panel B), whereas age was significantly related to viral RNA quantities (panel C). Moreover, viral RNA quantities were not significantly associated with sex (panel D), medical comorbidities (panel E), and obesity (panel F).aP < 0.05, bP < 0.01, and cP < 0.001, Wilcoxon signed rank test (unadjusted) and generalized estimating equations in which age, sex, medical comorbidity, obesity, and/or anatomical location were included as confounding variables (adjusted).
Changes in viral RNA quantity and cytokine levels in virus-infected culture supernatants between 24 and 72 h post-infection
| 24 h post-infection | 72 h post-infection | Percentage Change | FDR | |||||
|---|---|---|---|---|---|---|---|---|
| Mean | SEM | Mean | SEM | Mean | SEM | |||
| Viral RNA quantity | 5.76 | 0.18 | 7.21 | 0.19 | 11363 | 4256 | < 0.001 | 0.007a |
| IL-1β | 0.89 | 0.13 | 1.39 | 0.13 | 986 | 301 | < 0.001 | 0.014a |
| IL-6 | 3.85 | 0.13 | 3.89 | 0.14 | 420 | 244 | 0.011 | 0.043a |
| IL-8 | 4.33 | 0.10 | 4.54 | 0.08 | 105 | 45 | 0.029 | 0.050a |
| IFN-γ | 1.76 | 0.07 | 2.02 | 0.09 | 215 | 53 | < 0.001 | 0.021a |
| IP-10 | 2.42 | 0.22 | 3.18 | 0.20 | 1193 | 772 | < 0.001 | 0.029a |
| TNF-α | 1.46 | 0.07 | 1.65 | 0.06 | 139 | 38 | 0.003 | 0.036a |
Abbreviations: FDR, false discovery rate; IFN, interferon; IL, interleukin; IP-10, IFN-γ-induced protein-10; TNF, tumor necrosis factor.
All values were log-transformed (the only exceptions being percentage changes) and compared using the Wilcoxon signed rank test.
a Indicates a statistically significant FDR when the Benjamini and Hochberg approach for multiple testing correction was applied.
Spearman's correlations between viral RNA quantity and cytokine levels in virus-infected culture supernatants between 24 and 72 h post-infection
| Cytokine | Viral RNA quantity at 24 h post-infection | Viral RNA quantity at 72 h post-infection | ||||
|---|---|---|---|---|---|---|
| p | FDR | p | FDR | |||
| IL-1β | - 0.061 | 0.762 | 0.050 | 0.438 | 0.022 | 0.025a |
| IL-6 | - 0.090 | 0.656 | 0.033 | 0.060 | 0.765 | 0.042 |
| IL-8 | 0.073 | 0.718 | 0.042 | - 0.034 | 0.865 | 0.050 |
| IFN-γ | 0.175 | 0.383 | 0.025 | 0.305 | 0.122 | 0.033 |
| IP-10 | 0.625 | < 0.001 | 0.008a | 0.530 | 0.004 | 0.017a |
| TNF-α | 0.478 | 0.012 | 0.017a | 0.683 | < 0.001 | 0.008a |
Abbreviations: FDR, false discovery rate; IFN, interferon; IL, interleukin; IP-10, IFN-γ-induced protein-10; TNF, tumor necrosis factor.
a Indicates a statistically significant FDR when the Benjamini and Hochberg approach for multiple testing correction was applied.
Spearman's correlations between patient-related characteristics, changes in viral RNA quantities, and changes in core cytokine levels in virus-infected culture supernatants between 24 and 72 h post-infection
| Changes in Viral RNA Quantities/Cytokine Levels | Age ≥ 65 Years | Male Sex | Medical Comorbidities | Obesity | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDR | FDR | FDR | FDR | |||||||||
| Viral RNA quantity | - 0.127 | 0.527 | 0.036 | −0.021 | 0.918 | 0.050 | 0.163 | 0.417 | 0.007 | 0.600 | 0.001 | 0.007a |
| IL-1β | - 0.080 | 0.690 | 0.050 | - 0.073 | 0.718 | 0.029 | - 0.109 | 0.590 | 0.029 | - 0.454 | 0.017 | 0.021a |
| IL-6 | 0.282 | 0.154 | 0.007 | 0.125 | 0.533 | 0.014 | - 0.076 | 0.706 | 0.036 | - 0.223 | 0.264 | 0.036 |
| IL-8 | 0.222 | 0.267 | 0.021 | 0.167 | 0.405 | 0.007 | - 0.005 | 0.979 | 0.050 | - 0.238 | 0.232 | 0.029 |
| IFN-γ | - 0.147 | 0.464 | 0.029 | 0.052 | 0.796 | 0.036 | 0.119 | 0.553 | 0.021 | - 0.131 | 0.514 | 0.050 |
| IP-10 | 0.255 | 0.199 | 0.014 | - 0.052 | 0.796 | 0.043 | 0.044 | 0.829 | 0.043 | - 0.465 | 0.014 | 0.014a |
| TNF-α | 0.120 | 0.549 | 0.043 | −0.094 | 0.642 | 0.021 | 0.152 | 0.449 | 0.014 | 0.152 | 0.449 | 0.043 |
Abbreviations: FDR, false discovery rate; IFN, interferon; IL, interleukin; IP-10, IFN-γ-induced protein; TNF, tumor necrosis factor.
a Indicates a statistically significant FDR when the Benjamini and Hochberg approach for multiple testing correction was applied.
Figure 3Changes in core cytokine levels in virus-infected culture supernatants in relation to the anatomical sites of the explant and patients’ age, sex, medical comorbidities, and obesity (panels A–E)
aP < 0.05, bP < 0.01, and cP < 0.001, generalized estimating equations in which age, sex, medical comorbidity, obesity, and/or anatomical location were included as confounding variables.
Figure 4Schematic representation of the potential mechanisms by which different patient-related characteristics might influence the severity of infection
Patient-related characteristics may influence: 1) The replication kinetics of the H7N9 virus; and 2) the individual cytokine response. The H7N9 virus can replicate equivalently in the epithelial cells obtained from the upper and lower anatomical locations, which may be negatively affected by age (≥ 65 years). After H7N9 infection, the anatomical location and patient-related characteristics are significantly positively, negatively, or miscellaneously associated with elevated levels of certain core cytokines.